España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Mad Money Lightning Round
Jim Cramer: This Financial Stock Is 'One Of The Most Consistent, Great Companies'
Jim Cramer Says Buy CrowdStrike Stock, Calls This Aerospace Manufacturer A 'High Speculative' Stock
Jim Cramer: 'Avoid' This Consumer Cyclical Stock, Buy Lam Research
Jim Cramer Says Buy CrowdStrike Stock, Calls This Aerospace Manufacturer A 'High Speculative' Stock
Jim Cramer: 'Avoid' This Consumer Cyclical Stock, Buy Lam Research
Jim Cramer: Buy Broadcom, But Stay Away From These Stocks
Jim Cramer Says He Would Not Buy This Health Care Stock At This Level: 'Wait For A Pullback'
Jim Cramer: Buy Broadcom, But Stay Away From These Stocks
Jim Cramer Says He Would Not Buy This Health Care Stock At This Level: 'Wait For A Pullback'
Jim Cramer Says 'Hold On' To Palantir, 'Let Them Walk It Up'; Warns That Travere Therapeutics Is Losing A 'Ton Of Money'
Jim Cramer Calls AST SpaceMobile 'Overvalued,' Warns HubSpot Is 'Playing With Fire'
Read More...
Mad Money Lightning Round Recent News
Jim Cramer Says This Energy Stock Is A Buy: 'It Can Make Money Even At These Levels'
Cramer discusses Energy Transfer, Walgreens, Coterra Energy, e.l.f. Beauty and Dover on the latest edition of "Mad Money."
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
Jim Cramer believes Uranium Energy Corp. is going higher, thanks to a recent acquisition deal. Novo Nordisk faces antitrust concerns while Halliburton gets a Buy rating from BofA Securities.
Jim Cramer Is Worried About This Plane Maker, Says Palo Alto Is A 'Good' One
Jim Cramer gives Palo Alto Networks a shout-out; Morgan Stanley analyst Hamza Fodderwala recently raised the price target to $421.
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Reddit, which went public earlier this year.
Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
Target (TGT) stock recommended by Jim Cramer at current price with plans to buy more. Merck (MRK) and Unity Software (U) also discussed.
Jim Cramer: VICI Properties Is 'Fine', Recommends Buying This Energy Stock
Jim Cramer discusses VICI Properties, Pure Storage, STMicroelectronics, Crown Castle, Tetra Tech and New Fortress Energy.
Jim Cramer: AST SpaceMobile Is 'Just Too Hot,' Recommends Buying This Tech Stock
On CNBC's "Mad Money Lightning Round," Jim Cramer said FTAI Aviation is "too high" for him and prefers to be in RTX Corporation.
Jim Cramer Recommends Holding On To This Car Manufacturer, But As For Peloton? 'Take The Loss'
On CNBC's "Mad Money," Jim Cramer discussed Peloton, NIO and AMN Healthcare.
Jim Cramer: This Consumer Defensive Stock Is A Buy, Archer-Daniels-Midland Is A 'Value Trap'
On CNBC's "Mad Money Lightning Round," Jim Cramer said NANO Nuclear Energy Inc. is losing a "lot of money."
Jim Cramer Says This Utilities Stock Is A Buy: 'We Need Cheap Power'
On CNBC's "Mad Money Lightning Round," Jim Cramer said Dominion Energy, Inc. is a buy. "We need cheap power," he noted.
Jim Cramer: Viking Has 'Many Ships Coming In' (CORRECTED)
Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
Jim Cramer: This Utilities Stock Is A Buy, Calls Wells Fargo A 'Winner'
Wells Fargo is going to go higher, according to Jim Cramer. It's a "winner," the "Mad Money Lightning Round" host said.
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity Residential. Moderna has been disappointing, but Cramer likes Vertiv and Powell Industries as buys.
'If You Want Steel, You Do Nucor,' Says Cramer When Asked About Gerdau
Jim Cramer said Gerdau S.A. is a company that he doesn't really care for. "If you want steel, you do Nucor," he added.
IonQ Is Losing 'Too Much Money' While This Tech Stock Is 'Real Deal': Jim Cramer
IonQ shares rose 2.1% to close at $7.38 during Thursday's session. Cramer also discusses Garmin, MongoDB and CommScope.
PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate'
PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solution.
Jim Cramer: 'Not The Time To Own Oil,' When Asked About Exxon Mobil; Says IBM Is 'Performing Well'
Jim Cramer advises holding Advance Auto Parts (AAP) despite poor earnings. He recommends Citigroup (C) and JPMorgan (JPM) and praises IBM's (IBM) reinvented CEO. IES Holdings (IES) and Exxon Mobil (XOM) see mixed reactions.
Jim Cramer Says AES Is 'Very Inexpensive', Recommends Buying This Industrial Stock
Jim Cramer talks AES, NextEra Energy and Vertiv on CNBC's "Mad Money Lightning Round." As for Hertz, he's "very concerned."
Jim Cramer: Veralto Is A 'Well-Run' Company, Likes This Utilities Stock
Cramer is not sure how much higher Veralto can go unless it makes an acquisition or accelerates earnings, and he doesn't see that happening.
Jim Cramer Doesn't Like Carnival Right Now: Royal Caribbean Is 'The One You Want'
Royal Caribbean has "the best systems right now," Jim Cramer says. "It's got the best numbers. It's the one you want, not Carnival."
Jim Cramer: Oklo Is Losing Money 'Hand-Over-Fist,' But This Private Equity Stock Is A Buy
The "Mad Money" host said Oklo Inc. is a company that is again losing so much money "I can't even look at it."